SCHEMBL7159281

SCHEMBL7159281

O=P(OCl)(OBr)Oc1c[nH]c2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 2/20 0.44
PBRM1 Q86U86 1/20 0.37
ATM Q13315 3/20 0.36
GPR84 Q9NQS5 2/20 0.36
CYP2A6 P11509 1/20 0.36
IMPDH2 P12268 1/20 0.36
NR4A2 P43354 2/20 0.35
CREBBP Q92793 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
AHR P35869 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
ALDH1A1 P00352 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1853697 0.84 SLC22A6 (0.54) SLC22A6PBRM1ATMGPR84CYP2A6
SCHEMBL3279763 0.79 SLC22A6 (0.50) SLC22A6PBRM1ATMGPR84CYP2A6
SCHEMBL28034562 0.79 SLC22A6 (0.50) SLC22A6PBRM1ATMGPR84CYP2A6
SCHEMBL29769232 0.74 SLC22A6 (0.51) SLC22A6PBRM1ATMGPR84CYP2A6
SCHEMBL540158 0.74 SLC22A6 (0.56) SLC22A6PBRM1ATMGPR84CYP2A6
SCHEMBL31034497 0.74 SLC22A6 (0.56) SLC22A6PBRM1ATMGPR84CYP2A6
SCHEMBL460942 0.74 SLC22A6 (0.51) SLC22A6PBRM1ATMGPR84CYP2A6
SCHEMBL5638234 0.74 SLC22A6 (0.51) SLC22A6PBRM1ATMGPR84CYP2A6
SCHEMBL27808262 0.72 SLC22A6 (0.57) SLC22A6PBRM1ATMGPR84NR4A2
SCHEMBL30681608 0.71 RHEB (0.45) MEN1KMT2ACYP3A4MAPTAHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190153083-A1 NOVEL PEPTIDE STRUCTURES AND USE THEREOF IN THE TREATMENT OF TOXOPLASMOSIS UNIVERSITE DE TOURS (FR) 2019-05-23 US disclosed
EP-3442565-A1 NOVEL PEPTIDE STRUCTURES AND USE THEREOF IN THE TREATMENT OF TOXOPLASMOSIS Université de Tours (FR) 2019-02-20 EP disclosed
EP-3264081-B1 DRY CHEMICAL TEST STRIP WITH MULTIPLE LAYERS OF MEMBRANES BASED ON CONCENTRATION GRADIENT ZENG RONGBIN (CN) 2018-08-01 EP disclosed
EP-3264081-A1 DRY CHEMICAL TEST STRIP WITH MULTIPLE LAYERS OF MEMBRANES BASED ON CONCENTRATION GRADIENT Zeng, Rongbin (CN) 2018-01-03 EP disclosed
WO-2017178755-A1 NOVEL PEPTIDE STRUCTURES AND USE THEREOF IN THE TREATMENT OF TOXOPLASMOSIS UNIVERSITE FRANCOIS RABELAIS (FR) 2017-10-19 WO disclosed
EP-2691534-B1 ADIPONECTIN RECEPTOR C-TERMINAL FRAGMENTS (CTF)-IMMUNOGLOBULIN SIEMENS HEALTHCARE DIAGNOSTICS INC (US) 2017-07-26 EP disclosed
US-9664672-B2 Dry chemical test strip with multiple layers of membranes based on concentration gradient ZENG, Rongbin (CN) 2017-05-30 US disclosed
US-20170074865-A1 DRY CHEMICAL TEST STRIP WITH MULTIPLE LAYERS OF MEMBRANES BASED ON CONCENTRATION GRADIENT ZENG, Rongbin (CN) 2017-03-16 US disclosed
US-9291629-B2 Adiponectin receptor C-terminal fragments (CTF)-immunoglobulin SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) 2016-03-22 US disclosed
US-20140038890-A1 ADIPONECTIN RECEPTOR C-TERMINAL FRAGMENTS (CTF)-IMMUNOGLOBULIN SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) 2014-02-06 US disclosed
EP-2691534-A2 ADIPONECTIN RECEPTOR C-TERMINAL FRAGMENTS (CTF)-IMMUNOGLOBULIN Siemens Healthcare Diagnostics Inc. (US) 2014-02-05 EP disclosed
WO-2012141792-A2 ADIPONECTIN RECEPTOR C-TERMINAL FRAGMENTS (CTF)-IMMUNOGLOBULIN SIEMENS HEALTHCARE DIAGNOSTICS, INC. (US) 2012-10-18 WO disclosed
US-6538126-B1 Polynucleotides of given sequence derived from CDNA LUCKY LIMITED (KR) 2003-03-25 US disclosed